Immutep Limited (NASDAQ: IMMP) shares are trading down -26.19% at $4.2 at the time of writing after reporting that its Chinese partner, EOC Pharma will begin a new Phase II clinical trial in up to 152 metastatic breast cancer patients in China. Company’s 52-week ranged between $0.53 to $3.10. Analysts have a consensus price target …
Market Movers: What changed for these 37 stocks while you were sleeping Read More »
Apple Inc (AAPL) was able to make it to the “holiday season” and introduce two potentially lucrative products from December 14: new Max headphones for airpods and Apple Fitness+ subscriptions. In 2021, new products are likely to become new growth drivers. Fans of Apple products have been waiting for the last two new products in …
Max AirPods And Fitness+ Could Help Apple (AAPL) Stock Rise Ahead Read More »
The evolution of the share price of Nvidia (NVDA) has been one of the most remarkable in the last decade, going from $5.7 in 2009 to more than $500 in 2020, in a bull market of a magnitude that few stocks have been able to equal in that period. Nvidia is one of the Nasdaq’s …
On December 10, the American stock indexes finished trading in different directions. The S&P 500 Index dropped 0.13% to 3668 points, the Dow Jones lost 0.23% and the NASDAQ rose 0.54%. Investors could not determine the direction of movement and took a wait and see attitude. Note that small-cap stocks showed more pronounced positive dynamics: …
Early Morning Vibes: 3 Upgraded & 4 Pre Market Hot Stocks Inside Read More »
Oil in London has risen above $50 a barrel for the first time since the pandemic brought the global economy to a halt in a remarkable rally that few predicted would soon happen. International index futures rose 2.8% on Thursday to a nine-month peak. The revival is a startling reversal for a business brought to …
Unlike other commodity groups, gold prices have a connection to uncertainty. While other asset groups, such as bonds and securities, do not like higher volatility, demonstrate higher confusion regarding cash flows, dividends, coupon payments, etc., during times of greater volatility, gold appears to profit. Increased stock market volatility due to growing macroeconomic pressures is increasing …
Biotech and Major Pharmaceuticals are back in the news with the Covid-19 Pandemic. Life science investors basically endorse developments that might decide the human race’s future, but what would invest in ‘cures’ mean from a cash flow point of view? On Thursday, a panel of independent health professionals voted 17-4 in support of the Food …
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) shares hiked 32.30% to reach $8.11 in the pre-market session after the announcement that they have reached a license and supply agreement for exclusive rights to market and sell products in the United States for over-the-counter (OTC) dermatological products. Crown plans to sell Sonoma’s Microcyn technology dermal sprays and gels …
Nabriva Therape Ads (NBRV), shares price dropped -15% to $2.89 in the after-market sessionas a biopharmaceutical company specializing in the development andcommercialization of new antibiotics for treatment of serious infections,announced the pricing of its public offering of 6,000,000 ordinary shares at a price of $2.50 per share (or pre-funded warrant). In connection with this offering, …
Why Nabriva Therape Ads (NBRV) stock plummeted in the after-hours trading? Read More »
Amplify Energy Corp. (NYSE: AMPY) stock value dropped -19.33% to $1.21 in the after-hours after Company announced the commencement of an underwritten public offering of 8,548,485 shares of its common stock by certain of its stockholders, which are affiliates of Fir Tree Capital Management L.P. Amplify will not sell any shares of its common stock …
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.